FindTrial
Sign In

Chemotherapy With DNA Damaging Agents In Colorectal Cancer

Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01456923
Enrollment
Unknown
Registered
2011-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2011-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

DNA damaging agents

Brief summary

Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.

Interventions

OTHERTreatment with chemotherapy
OTHEROnly chemotherapy treatment for study cohort

Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy

PROCEDUREsurgery

Sponsors

Centro Hospitalar Nordeste
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

\- patients that did not underwent surgery

Exclusion criteria

\- patients that underwent surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026